Prevalence of metabolic syndrome among inpatients with schizophrenia

International Journal of Psychiatry in Medicine

Volumn 38, Issue 1, 2008, Pages 103-112

  Boke, Omer ^a,c   Aker, Servet ^a   Sarisoy, Gokhan ^a   Saricicek, Esin Boke ^b   Sahin, Ahmet Rifat ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b Samsun Mental Health Hospital Laboratory   (Turkey)

^c University of 19 Mayis   (Turkey)

Author keywords

Mental hospital; Metabolic syndrome; Schizophrenia

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NEUROLEPTIC AGENT; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MENTAL HOSPITAL; METABOLIC SYNDROME X; OBESITY; POPULATION; PREVALENCE; SCHIZOPHRENIA; TRIACYLGLYCEROL BLOOD LEVEL; TURKEY (REPUBLIC); WAIST CIRCUMFERENCE; ADOLESCENT; BLOOD; COMORBIDITY; COMPARATIVE STUDY; GLUCOSE INTOLERANCE; HOSPITALIZATION; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PSYCHOLOGICAL RATING SCALE; RISK FACTOR; SEX RATIO; STATISTICS;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HOSPITALIZATION; HOSPITALS, PSYCHIATRIC; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OVERWEIGHT; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SCHIZOPHRENIA; SEX DISTRIBUTION; TRIGLYCERIDES; TURKEY;

EID: 50649117372     PISSN: 00912174     EISSN: 15413527     Source Type: Journal    
DOI: 10.2190/PM.38.1.j     Document Type: Article

References (27)

1. Hannerz H, Borga P, Boritz M. Life expectancies for individuals with psychiatric diagnosis. Public Health 2001;115:125-142.
2. Holt RIG, Pevelert RC, Byrne CD. Schizophrenia, the metabolic syndrome and diabetes. Diabetic Medical Journal 2004;21:515-523.
3. Meyer J, Loh C, Leckband SG, Boyd JA, Wirshing WC, Pierre J, Wirshing D. Prevalence of the metabolic syndrome in Veterans with schizophrenia. Journal of Psychiatric Practice 2006;12:5-10.
4. Susman N. Review of atypical antipsychotics and weight gain. Journal of Clinical Psychiatry 2001;62:5-12.
5. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistence syndrome (syndrome X). Diabetes 1992;41:715-722.
6. Chandran M, Philips S, Ciaraldi T, Henry RR. Adiponectin: More than just another fat cell hormone? Diabetes Care 2003; 26:2442-2450.
7. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
8. Grundy SM. Hypertrigliseridemia, insulin resistence, and the metabolic syndrome. American Journal of Cardiology 1999; 83: 25F-29F.
9. Kozan O, Oǧuz A, Abaci A, Erol C, Ongen Z, Temizhan A, Celik, S. Prevalence of the metabolic syndrome among Turkish adults. European Journal of Clinical Nutrition 2007; 61: 548-553.
10. Srisurapanont M, Likhitsathian S, Boonyanaruthee V, Charnsilp C, Jarusuraisin N. Metabolic syndrome in Thai schizophrenic patients: A naturalistic one-year follow-up study. BMC Psychiatry 2007; 7:14 doi:10.1186/1471-244X-7-14.
11. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005;366:1059-1062.
12. Kato MM, Currier MB, Gomez CM, Hall CM, Gonzales-Blanco M. Prevalence of metabolic syndrome in Hispanic and non-Hispanic patients with schizophrenia. Primary Care Companion Journal of Clinical Psychiatry 2004;6:74-77.
13. Heiskanen T, Niskanen L, Lyytikainen R, Saarinen PI, Hintikka J. Metabolic syndrome in patients with schizophrenia. Journal of Clinical Psychiatry 2003;64:575-579.
14. Citrome L. Metabolic syndrome and cardiovascular disease. Journal of Psychopharmacology 2005;19 84-93.
15. Cohn T, Prud'homme D, Streiner D, Kameh H, Remington G. Characterizing coronary heart disease risk in chronic schizophrenia: High prevalence of the metabolic syndrome. Canadian Journal of Psychiatry 2004;49:753-760.
16. De Hert MA, Winkel R, Van Eyck D, Hanssens L, Wampers M, Schen A. Peuskens J. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. Schizophrenia Research 2006;83:87-93.
17. Newcomer JW. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. Journal of Clinical Psychiatry 2007;68(Suppl)1:20-27.
18. Ryan MCM, Thakore JH. Physical consequences of schizophrenia and its treatment: The metabolic syndrome. Life Sciences 2002;71:239-257.
19. McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, Meltzer HY, Hsiao J, Scott Stroup T, Lieberman JA. Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Trials of Intervention Effectiveness(CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia Research 2005;80:19-32.
20. Correl CU, Frederickson AM, Kane JM, Manu P. Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs. Journal of Clinical Psychiatry 2006;67:575-583.
21. Hagg S, Lindblom Y, Mjorndal T, Adolfsson R. High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia. International Journal of Clinical Psychopharmacology 2006;21:93-98.
22. Karakas G, Orsel S, Ugurlu M, Ozbay MH, Turkcapar H, Berber S. Sizofreni hastalarinda metabolic sendrom yayginligi. 42. National Psychiatry Congress 2006 Istanbul(In Turkish).
23. Cerit C, Özten E, Yildiz M. The Prevalence of Metabolic Syndrome and Related Factors in Patients With Schizophrenia. Turk Psikiyatri Dergisi 2007;18:article in press.
24. Meyer J, Koro CE, L'italien J. The metabolic syndrome and schizophrenia: A review. International Review of Psychiatry 2005;17:173-180.
25. Meyer JM. Cardiovascular illness and hyperlipidemia in patients with schizophrenia. In: Meyer JM, Nasrallah HA, editors. Medical illness and schizophrenia. Arlington, VA: American Psychiatric Publishing, 2003: 53-58.
26. Canas F, Benegas JR, Bernardo M, Casademont X, Riesgo Y, Varela C, Ricava study group. Cardiovascular risk factors in patients with schizophrenia in Spain: RICAVA study. Schizophrenia Research 2006;81(Suppl 1): 177.
27. Laksonen DE, Laka HM, Salonen JT, Niskanen LK, Rauramaa R, Lakka TA. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care 2005;25:1612-1618.